• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

bidding war

Pharma

J&J lost to Pfizer in $5.4B GBT bidding war: Bloomberg

Known as “company A,” J&J was the one that set off the deal talks by proactively contacting GBT with a buyout offer before Pfizer came in.
Angus Liu Aug 24, 2022 10:15am

Immunomedics' deal mastermind in line for $2.35B payout

Sep 25, 2020 10:45am

China's Fosun eyes a joint bid for Bayer animal health: report

Jun 18, 2019 10:57am

How Spark’s search for a hem A collab turned into a bidding war

Mar 8, 2019 12:47pm

Hot buyout target Stada rolls out cost-cutting drive

Mar 17, 2017 10:09am

Stada has its first real buyout offer. Is a bidding war next?

Feb 23, 2017 9:23am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy